List of SBIR/STTR awards granted to NovoMedix
NovoMedixName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to NovoMedix in September, 2019 for $375,001.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL147726-01A1 | Phase I | 375,001 | September 19, 2019 | |||||||
A SBIR Phase I contract was awarded to NovoMedix in September, 2021 for $375,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL160460-01 | Phase I | 375,000 | September 1, 2021 | |||||||
A SBIR Phase II contract was awarded to NovoMedix in May, 2022 for $1,062,913.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44HL164314-01 | Phase II | 1,062,913 | May 16, 2022 | |||||||
A SBIR Phase I contract was awarded to NovoMedix for $355,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 75N91022C00001 | Phase I | 355,000 | ||||||||
A SBIR Phase I contract was awarded to NovoMedix in April, 2016 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL131356-01A1 | Phase I | 300,000 | April 1, 2016 | |||||||
A SBIR Phase II contract was awarded to NovoMedix for $2,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA144156-02 | Phase II | 2,000,000 | ||||||||
A SBIR Phase I contract was awarded to NovoMedix for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA165739-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to NovoMedix for $300,236.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA144156-01A1 | Phase I | 300,236 | ||||||||
A SBIR Phase I contract was awarded to NovoMedix for $516,697.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK077285-01 | Phase I | 516,697 |
